Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xingpi Capsule (also known as Spleen-awakening Capsule) is a Traditional Chinese Medicine (TCM) formulation primarily used in China for the treatment of functional gastrointestinal disorders, including irritable bowel syndrome (IBS) and functional dyspepsia. The formulation is designed to "awaken the spleen" and "harmonize the stomach," addressing symptoms such as abdominal pain, bloating, diarrhea, and poor appetite. It typically comprises a synergistic blend of herbal extracts, including *Atractylodes macrocephala*, *Poria cocos*, and *Amomum villosum*. Clinical research, including real-world observational studies conducted by the China Academy of Chinese Medicine Sciences, has evaluated its efficacy in improving gastrointestinal symptoms as well as associated psychological comorbidities like anxiety and depression in adult patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xingpi capsule.